Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Functional characterization of pendrin mutations found in the Israeli and Palestinian populations.
[pendred syndrome]
Pendrin
is
a
transport
protein
exchanging
chloride
for
other
anions
,
such
as
iodide
in
the
thyroid
gland
or
bicarbonate
in
the
inner
ear
.
Mutations
in
the
SLC
26
A
4
gene
encoding
for
pendrin
are
responsible
for
both
syndromic
(
Pendred
syndrome
)
and
non-syndromic
(
non-syndromic
enlarged
vestibular
aqueduct
,
EVA
)
hearing
loss
.
Besides
clinical
and
radiological
assessments
,
molecular
and
functional
studies
are
essential
for
the
correct
diagnosis
of
Pendred
syndrome
and
non-syndromic
EVA
.
While
a
broad
spectrum
of
mutations
found
in
the
Caucasian
population
has
been
functionally
characterized
,
little
is
known
about
mutations
specifically
occurring
in
the
populations
of
the
Middle
East
.
Here
we
show
the
characterization
of
the
ion
transport
activity
of
three
pendrin
mutations
previously
found
in
deaf
patients
with
EVA
in
the
Israeli
Jewish
and
Palestinian
Arab
populations
,
i
.
e
.
V
239
D
,
G
334
V
X
335
and
I
487
Y
FSX
39
.
Wild
type
and
mutated
pendrin
allelic
variants
were
functionally
characterized
in
a
heterologous
over-expression
system
.
The
Cl
(
-
)
/
I
(
-
)
and
Cl
(
-
)
/
OH
(
-
)
exchange
activities
were
assessed
by
fluorometric
methods
suitable
for
measuring
iodide
fluxes
and
the
intracellular
pH
.
Both
the
Cl
(
-
)
/
I
(
-
)
and
the
Cl
(
-
)
/
OH
(
-
)
exchange
activities
of
pendrin
V
239
D
,
G
334
V
X
335
and
I
487
Y
FSX
39
were
significantly
reduced
with
respect
to
the
wild
type
,
with
V
239
D
displaying
a
residual
iodide
transport
.
Functional
assays
confirmed
the
diagnosis
of
non-syndromic
EVA
due
to
SLC
26
A
4
mutations
performed
by
radiological
and
molecular
tests
in
deaf
patients
belonging
to
the
Israeli
Jewish
and
Palestinian
Arab
populations
.
The
new
finding
that
the
V
239
D
mutation
displays
residual
function
suggests
that
the
symptoms
caused
by
this
mutation
could
be
ameliorated
by
a
pendrin
'
activator
'
,
if
available
.
Diseases
Validation
Diseases presenting
"hearing loss"
symptom
22q11.2 deletion syndrome
achondroplasia
adrenomyeloneuropathy
alexander disease
benign recurrent intrahepatic cholestasis
canavan disease
cohen syndrome
congenital toxoplasmosis
dentinogenesis imperfecta
fabry disease
familial mediterranean fever
heparin-induced thrombocytopenia
hirschsprung disease
holt-oram syndrome
homocystinuria without methylmalonic aciduria
hydrocephalus with stenosis of the aqueduct of sylvius
kabuki syndrome
kallmann syndrome
neonatal adrenoleukodystrophy
pendred syndrome
von hippel-lindau disease
wolf-hirschhorn syndrome
This symptom has already been validated